See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Trip.com Group Limited Sponsored ADR (TCOM) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Trip.com Group Limited Sponsored ADR (TCOM) - free report >>
Image: Bigstock
Best Momentum Stocks to Buy for October 7th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 7th:
Montauk Renewables, Inc. (MNTK - Free Report) : This biogas focused renewable energy company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.3% over the last 60 days.
Montauk Renewables, Inc. Price and Consensus
Montauk Renewables, Inc. price-consensus-chart | Montauk Renewables, Inc. Quote
Montauk’s shares gained 44.8% over the last three months compared with the S&P 500’s decline of 3.4%. The company possesses a Momentum Score of A.
Montauk Renewables, Inc. Price
Montauk Renewables, Inc. price | Montauk Renewables, Inc. Quote
Larimar Therapeutics, Inc. (LRMR - Free Report) : This clinical-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 23.3% over the last 60 days.
Larimar Therapeutics, Inc. Price and Consensus
Larimar Therapeutics, Inc. price-consensus-chart | Larimar Therapeutics, Inc. Quote
Larimar’s shares gained 65.6% over the last three months compared with the S&P 500’s decline of 3.4%. The company possesses a Momentum Score of A.
Larimar Therapeutics, Inc. Price
Larimar Therapeutics, Inc. price | Larimar Therapeutics, Inc. Quote
Trip.com Group Limited (TCOM - Free Report) : This travel service provider for the leisure and recreation industry has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 46.2% over the last 60 days.
Trip.com Group Limited Sponsored ADR Price and Consensus
Trip.com Group Limited Sponsored ADR price-consensus-chart | Trip.com Group Limited Sponsored ADR Quote
Trip.com’s shares gained 10.6% over the last three months compared with the S&P 500’s decline of 3.4%. The company possesses a Momentum Score of B.
Trip.com Group Limited Sponsored ADR Price
Trip.com Group Limited Sponsored ADR price | Trip.com Group Limited Sponsored ADR Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.